Could a simple pill replace IV tests for parathyroid disease?
NCT ID NCT01103206
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a single dose of the drug cinacalcet can be used to measure how well the body suppresses parathyroid hormone (PTH). Researchers compare this pill-based test to the standard intravenous calcium test in healthy adults, and also compare results between healthy people and those with primary hyperparathyroidism. The goal is to see if the cinacalcet test is a reliable, simpler alternative for diagnosis and monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cinacalcet
What this could lead to
If successful, this could provide a simpler, pill-based test for diagnosing and monitoring primary hyperparathyroidism.
What could go wrong
This is a small, early-phase study with only 36 participants. The test may not prove accurate enough for routine use, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARATHYROID HORMONE SUPPRESSION TEST WITH CINACALCET are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University hospital
Rouen, Haute Normandie, 76031, France